Short Interest in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Grows By 30.5%

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) saw a large growth in short interest in September. As of September 15th, there was short interest totalling 997,700 shares, a growth of 30.5% from the August 31st total of 764,600 shares. Approximately 1.8% of the shares of the stock are sold short. Based on an average daily volume of 328,600 shares, the short-interest ratio is currently 3.0 days.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on AVAH shares. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Aveanna Healthcare from $3.00 to $5.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. Royal Bank of Canada boosted their price objective on shares of Aveanna Healthcare from $3.00 to $5.00 and gave the stock a “sector perform” rating in a research report on Friday, August 9th. Finally, UBS Group boosted their price objective on shares of Aveanna Healthcare from $1.70 to $2.80 and gave the stock a “sell” rating in a research report on Friday, August 9th.

Institutional Trading of Aveanna Healthcare

Large investors have recently bought and sold shares of the company. Mackenzie Financial Corp boosted its stake in shares of Aveanna Healthcare by 35.9% during the 2nd quarter. Mackenzie Financial Corp now owns 45,674 shares of the company’s stock valued at $126,000 after buying an additional 12,075 shares during the last quarter. Renaissance Technologies LLC lifted its stake in Aveanna Healthcare by 155.8% during the second quarter. Renaissance Technologies LLC now owns 158,600 shares of the company’s stock worth $438,000 after purchasing an additional 96,600 shares during the last quarter. Acadian Asset Management LLC lifted its stake in Aveanna Healthcare by 176.6% during the second quarter. Acadian Asset Management LLC now owns 81,275 shares of the company’s stock worth $222,000 after purchasing an additional 51,890 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in Aveanna Healthcare by 6.6% during the second quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company’s stock worth $413,000 after purchasing an additional 9,243 shares during the last quarter. Finally, Vanguard Group Inc. lifted its stake in Aveanna Healthcare by 1.8% during the first quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock worth $6,402,000 after purchasing an additional 44,970 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Price Performance

NASDAQ:AVAH traded down $0.11 on Friday, reaching $5.22. The stock had a trading volume of 199,138 shares, compared to its average volume of 177,163. Aveanna Healthcare has a 12-month low of $0.85 and a 12-month high of $5.95. The firm’s fifty day moving average is $4.93 and its two-hundred day moving average is $3.38. The company has a market cap of $1.01 billion, a price-to-earnings ratio of -8.88 and a beta of 2.13.

Aveanna Healthcare (NASDAQ:AVAH) last posted its earnings results on Thursday, August 8th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.03. The business had revenue of $504.96 million for the quarter, compared to analyst estimates of $494.02 million. As a group, research analysts forecast that Aveanna Healthcare will post -0.09 earnings per share for the current fiscal year.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.